Paper Details

  1. Home
  2. Paper Details

Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes.

Author: AlticeFrederick L, DvoriakSergii, FilippovichSergii, MakarenkoIuliia, MarcusRuthanne, MazhnayaAlyona, PykaloIryna, SpringerSandra A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

Extended-release naltrexone (XR-NTX) is a feasible treatment option for opioid use disorders (OUD) in Ukraine.
Paper Details　
Original Abstract of the Article :
Although opioid agonist treatments (OAT) with methadone or buprenorphine are available to treat opioid use disorders (OUD) in Ukraine, OAT acceptability and coverage remains low. Extended-release naltrexone (XR-NTX) that recently became available as another treatment option provides new opportunitie...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/31370983

データ提供：米国国立医学図書館（NLM）

Extended-Release Naltrexone: A New Oasis in the Desert of Opioid Dependence Treatment

Opioid dependence, a complex and multifaceted challenge, often necessitates specialized treatment approaches. This research investigates the feasibility and effectiveness of extended-release naltrexone (XR-NTX) as a treatment option for opioid use disorders (OUD) in Ukraine, a country grappling with this growing health crisis. The study, conducted in a clinical setting, explored the potential of XR-NTX in treating OUD, akin to searching for a new oasis in the desert of opioid addiction. The results indicated that XR-NTX was feasible and demonstrated promising outcomes in terms of reducing opioid use and improving patient well-being.

A New Path in the Desert of Opioid Dependence

The study's findings offer a new path in the treatment of opioid dependence. The feasibility and effectiveness of XR-NTX in Ukraine suggest that this medication could be a valuable tool for addressing the challenges of opioid addiction in this region. This is akin to finding a new oasis in the desert, providing a source of hope and a potential route toward recovery for individuals struggling with opioid dependence.

Finding a Sustainable Solution in the Desert of Addiction

This research highlights the importance of exploring new and innovative treatment options for opioid dependence. Just as a camel adapts to the harsh conditions of the desert, we must continue to seek sustainable solutions to address the challenges of opioid addiction. The study's findings suggest that XR-NTX could be a valuable tool for improving the lives of individuals battling opioid dependence.

Dr.Camel's Conclusion

This study presents a potential oasis in the desert of opioid dependence treatment, offering hope for a more sustainable and effective approach to addressing this challenging condition. The feasibility and effectiveness of XR-NTX in Ukraine suggest that this medication could be a valuable tool for improving the lives of those struggling with opioid addiction.

Date :
  1. Date Completed 2020-08-24
  2. Date Revised 2023-11-07
Further Info :

Pubmed ID

31370983

DOI: Digital Object Identifier

NIHMS1714334

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.